In Vitro Diagnostics – Market Insights – United States
The COVID-19 pandemic has negatively impacted the US IVD market, resulting in test volumes and revenue declines in 2020. However, following a period of recovery, the market will grow modestly through 2031, driven by the aging US population, the rise in incidences of chronic and infectious, diseases and the shift toward value-based healthcare, which will fuel the uptake of newer tests with the development of automated IVD systems, improved diagnostic accuracy and reduced turnaround time. The continuous increase in the launch of IVD products being launched by key players is also fueling the growth of the market
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IVDs in the US from 2019 through 2031.
The COVID-19 pandemic has negatively impacted the US IVD market to some extent.
How strongly has the US IVD market been impacted by the COVID-19 pandemic?
Which test types and segments have been most impacted?
At what pace is the market recovering?
The use of MDx tests will expand rapidly over the forecast period.
Which MDx tests will experience the highest growth throughout the forecast period?
How will adoption of MDx tests affect the other test segments in the IVD market?
The PAMA reimbursement revision will promote widespread pricing pressures and increase laboratory consolidation in the US.
How must vendors adjust their strategies to adapt to this trend?
How will the growth prospects of the market be affected?
How will test volumes between the different facility types be affected?
The IVD competitive landscape consists of large MNCs as well as smaller niche competitors specializing in specific segments and diseases.
How do strategies differ between MNCs and smaller companies in this space?
What are the key purchasing criteria laboratories consider when selecting an IVD manufacturer?
Table of contents
- In Vitro Diagnostics - Market Insights - United States
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- COVID-19 Analysis
- In Vitro Diagnostics Market
- Clinical Chemistry Test Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Clinical Chemistry Test Market, by Product Type, US (USD), 2019u20132031
- Clinical Chemistry Test Market, by Setting, US (USD), 2019u20132031
- Clinical Chemistry Test Market, by Test Type, US (USD), 2019u20132031
- General Chemistry Tests
- Diabetes Tests
- Therapeutic Drug Monitoring Tests
- Drug of Abuse Testing
- Specific Protein Tests
- Cardiac Marker
- Blood Gas
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Immunoassay Test Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Immunoassay Test Market, by Product Type, US (USD), 2019u20132031
- Immunoassay Test Market, by Setting, US (USD), 2019u20132031
- Immunoassay Test Market, by Test Type, US (USD), 2019u20132031
- Allergy Tests
- Anemia Tests
- Bone Metabolism Tests
- Cardiac Marker Tests
- Fertility/Hormone Tests
- Infectious Disease Tests
- Specific Protein
- Thyroid Tests
- Tumor Marker Tests
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Microbiology Test Market
- Hematology and Coagulation Test Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Hematology and Coagulation Test Market, by Product Type, US (USD), 2019u20132031
- Hematology and Coagulation Test Market, by Setting, US (USD), 2019u20132031
- Hematology and Coagulation Test Market, by Test Type, US (USD), 2019u20132031
- General Screening and Anticoagulation Monitoring Tests
- Prothrombin Time Tests
- D-Dimer Tests
- Fibrin Formation and Degradation Tests
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Molecular Diagnostic Test Market
- Appendix
Vijjapu Kameswara Rao is a healthcare research and data analyst on the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, specializing in endoscopy and imaging device markets. Kamesh holds a Bachelor’s degree in Pharmaceutical Sciences from the Jawaharlal Nehru Technological University Kakinada and a Master’s degree in Pharmaceutical Analysis from the National Institute of Pharmaceutical Education and Research, Mohali.